Problem to be solved: to provide effective treatment in cases of renal trauma, and in the management of a wide range of benign and malignant kidneys. A new therapeutic agent for the pathogenesis of the kidney including irradiated microparticlesA new therapeutic agent for the kidneyIt is used ...
Hypertension is an exceedingly common disorder in Western societies; but, thanks to improved management of chronic hypertension, the number of patients who... MS Pergolini - 《Clinica Terapeutica》 被引量: 34发表: 2009年 How should we treat hypertensive women with cardiac and renal impairment? Art...
Long-term oncologic outcomes of hand-assisted retroperitoneoscopic radical nephrectomy to treat clinically localized renal cell carcinoma Background/Purpose To evaluate the long-term oncological outcomes of hand-assisted retroperitoneoscopic radical nephrectomy (HARRN) for treating clinically... Shun-Fa,...
Renal cell carcinoma- advanced (CheckMate-025)Median duration of overall survival Opdivo: 25.8 months (95% CI 22.2-29.8) vs Everolimus: 19.7 months (95% CI 17.6-22.1) Progression-free survival was also improved in the Opdivo group Objective response rate ...
WALTER STADLER, MD How Do I Treat a Patient with Newly Diagnosed Metastatic Renal Cancer? BY WALTER STADLER, MDHow Do I Treat a Patient with Newly Diagnosed Metastatic Renal Cancer? BY WALTER STADLER, MDAn abstract is unavailable.StockwellSerena...
Hudes, G. et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.N. Engl. J. Med.356, 2271–2281 (2007). ArticleCASPubMedGoogle Scholar Motzer, R. J. et al. Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognost...
a kind of kidney cancer calledrenal cell carcinoma (RCC). It may be used in adults with the medicine axitinib as your first treatment when your kidney cancer has spread or cannot be removed by surgery (advanced RCC). It may be used alone if you are at intermediate-high or high risk of...
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N. Engl. J. Med. 356, 2271–2281 (2007). Article CAS PubMed Google Scholar Motzer, R. J. et al. Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors. ...
CT=chemotherapy; HCC=hepatocellular carcinoma; mNSCLC=metastatic non-small cell lung cancer; NSCLC=non-small cell lung cancer; Q3W=every 3 weeks; Q4W=every 4 weeks; uHCC=unresectable hepatocellular carcinoma. †uHCC: For patients with a body weight of ≥30 kg: IMJUDO 300 mg as a single...
regularly. Money, in some cases, will help you have more power and have more chances to get better work and life. It is necessary thing in your wealthy life. Money have a great power because you cannot live if you do not have foods to eat,waterto drink, or money to spend for works...